Creating Patient-centered Approaches to Optimal Care: Best Practices for Utilizing BCMA-directed Therapy

Treatment strategies for relapsed/refractory multiple myeloma (RRMM) are inevitably complex as oncology teams must consider patient-, treatment-, and disease-related factors in their decision-making. Tune into the last episode of the Med Table Talk^® Series on Creating Patient-centered Approaches to Optimal Care: Best Practices for Utilizing BCMA-directed Therapy, where our expert panel will discuss:

• Incorporating diagnostic and prognostic factors in treatment selection for patients with RRMM
• Evaluating the clinical evidence of treatment sequencing of BCMA-directed therapies
• Overcoming health inequities for vulnerable populations